Patent details
EP1239832 Title: SUSPENSION COMPRISING OXCARBAZEPINE
Basic Information
- Publication number:
- EP1239832
- PCT Application Number:
- PCT/EP/2000/012968
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP009888033
- PCT Publication Number:
- WO/2001/045671
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SUSPENSION COMPRISING OXCARBAZEPINE
- French Title of Invention:
- SUSPENSION DE OXCARBAZEPINE
- German Title of Invention:
- OXCARBAZEPINSUSPENSION
- SPC Number:
Dates
- Filing date:
- 19/12/2000
- Grant date:
- 23/06/2004
- EP Publication Date:
- 23/06/2004
- PCT Publication Date:
- 28/06/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/09/2002
- EP B1 Publication Date:
- 23/06/2004
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 19/12/2018
- Expiration date:
- 19/12/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/12/2000
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- BILLINGTON Michael
- Address:
- Switzerland (CH)
2
- Name:
- SIGG Juergen
- Address:
- Germany (DE)
Priority
- Priority Number:
- 9930058
- Priority Date:
- 20/12/1999
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 9/10;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 08/12/2017
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- MARKS & CLERK LLP
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/04/2019 | Outgoing Correspondence | 1 |